Dyslipidemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Global Dyslipidemia Epidemiology and Patient Flow Analysis - 2017 - PR Newswire (press release)



Global Dyslipidemia Epidemiology and Patient Flow Analysis - 2017 
PR Newswire (press release)
The report provides insights into Dyslipidemia epidemiology, Dyslipidemia diagnosed patients, and Dyslipidemia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Dyslipidemia derived from ...

and more » 


Dyslipidemia Market Advantages & Disadvantages 2017 to 2025 - Research of Market



Dyslipidemia Market Advantages & Disadvantages 2017 to 2025 
Research of Market
Dyslipidemia-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Dyslipidemia. The report provides a complete understanding of the pipeline activities covering all ...

and more » 


Gemphire to Present at the Piper Jaffray and LD Micro Investor Conferences - GlobeNewswire (press release)



Gemphire to Present at the Piper Jaffray and LD Micro Investor Conferences 
GlobeNewswire (press release)
LIVONIA, Mich., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia ...

and more » 


Dyslipidemia Drugs Market Key Trends, Players Analysis and Forecast - MilTech



Dyslipidemia Drugs Market Key Trends, Players Analysis and Forecast 
MilTech
Dyslipidemia Drugs market research is provided on past, current and anticipated market situations, market drivers, trends driving it, and the challenges faced by the market which will help in deciding corporate strategy, product strategy, marketing ...

and more » 


Dyslipidemia Industry -Epidemiology Forecast to 2025 Growth Forecast Research Report - Medgadget (blog)



Dyslipidemia Industry -Epidemiology Forecast to 2025 Growth Forecast Research Report 
Medgadget (blog)
?Dyslipidemia ? Epidemiology Forecast To 2025? provides an overview of the epidemiology trends of Dyslipidemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of ...

and more » 


Novel Indian discovered dyslipidemia drug approved in Mexico - The Pharma Letter



Hindu Business Line
 
Novel Indian discovered dyslipidemia drug approved in Mexico 
The Pharma Letter
Indian drugmaker Zydus Healthcare today announced that the Mexico regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval to commercialize Lipaglyn (saroglitazar magnesium) in ...
Zydus receives Mexican marketing approval for Lipaglyn to treat dyslipidemia pharmabiz.com
Zydus gets regulatory nod to market Lipaglyn in Mexico Hindu Business Line

all 7 news articles » 


Worldwide Dyslipidemia Drugs Market 2021 Analysis of Regions with Top vendors, Market Dynamics, Types ... - satPRnews (press release)



Worldwide Dyslipidemia Drugs Market 2021 Analysis of Regions with Top vendors, Market Dynamics, Types ... 
satPRnews (press release)
Dyslipidemia Drugs Market report to delivers information on major drivers, challenges and opportunities in Dyslipidemia Drugs industry with analysis on vendors, geographical regions, types, applications. The market also provides industry situations ...

and more » 


HIV-positive adults receive inferior cardiovascular care compared with those without HIV - EurekAlert (press release)



HIV-positive adults receive inferior cardiovascular care compared with those without HIV 
EurekAlert (press release)
... received aspirin/antiplatelet therapy for primary prevention or cardiovascular disease, while 13.8 percent of HIV-negative adults received such therapy. For patients who had diabetes, cardiovascular disease or dyslipidemia (abnormally elevated ...

and more » 


Dyslipidemia Drugs Market Opportunities, Threats Faced by the Key Vendors Analysis and Forecast - MilTech



Dyslipidemia Drugs Market Opportunities, Threats Faced by the Key Vendors Analysis and Forecast 
MilTech
Dyslipidemia Drugs market report provides actionable intelligence on factors that have been driving demand; key trends that are impacting the market; challenges that affect the market dynamics along with the market size, a SWOT analysis of the key ...

and more » 


Gemphire Therapeutics Presents Data at American Heart Association (AHA) Scientific Sessions Showing that ... - GlobeNewswire (press release)



Gemphire Therapeutics Presents Data at American Heart Association (AHA) Scientific Sessions Showing that ... 
GlobeNewswire (press release)
LIVONIA, Mich., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia ...

and more »